SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of Oxford vs ChAdOx1 – University of Oxford
Serious adverse eventsg
SII‐ChAdOx1 – Serum Institute of India/AstraZeneca + University of… showed no clear difference in serious adverse eventsg compared with chAdOx1 – University of Oxford (low certainty).
1 finding from 1 review
- RR 0.5 [0.08, 2.95]1 study · 400 participantsLow